Emergency contraception: No. 280 (Replaces No. 131, August 2003)

International Journal of Gynecology and Obstetrics

Volumn 120, Issue 1, 2013, Pages 102-107

  Dunn, Sheila ^a   Guilbert, Édith ^a   Burnett, Margaret ^a   Aggarwal, Anjali ^a   Bernardin, Jeanne ^a   Clark, Virginia ^b   Davis, Victoria ^c   Dempster, Jeffrey ^a   Fisher, William ^d   MacKinnon, Karen ^a   Pellizzari, Rosana ^e   Polomeno, Viola ^f   Rutherford, Maegan ^a   Sabourin, Jeanelle ^a   Senikas, Vyta ^f   Wagner, Marie Soleil ^a  

^a Moncton NB ^*  (Canada)

^b Golden BC   (Canada)

^c Scarborough on   (Canada)

^d Health Sciences Centre   (Canada)

^e Peterborough on   (Canada)

^f Ottawa Centre   (Canada)

Author keywords

Emergency contraception; Emergency contraceptive pills; IUD; Post coital contraception; Post coital copper intrauterine device

Indexed keywords

ALLESSE; ANTIEMETIC AGENT; COPPER INTRAUTERINE DEVICE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; LEVONORGESTREL; MIFEPRISTONE; MINOVRAL; NEXT CHOICE; POSTCOITUS CONTRACEPTIVE AGENT; UNCLASSIFIED DRUG;

ARTICLE; BREAST FEEDING; CANADA; CORPUS LUTEUM FUNCTION; DIZZINESS; DRUG APPROVAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MECHANISM; EMERGENCY CONTRACEPTION; ENDOMETRIUM; FATIGUE; FERTILIZATION; FOLLOW UP; HUMAN; MEDICAL HISTORY; MENSTRUATION; NAUSEA; OVARY FOLLICLE MATURATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPEATED DRUG DOSE; SINGLE DRUG DOSE; SPERMATOZOON MIGRATION; TREATMENT CONTRAINDICATION; UTERINE CERVIX MUCUS; VOMITING; ZYGOTE;

EID: 84871828785     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2012.09.006     Document Type: Article

References (73)

1. Task Force on Postovulatory Methods of Fertility Regulation. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998;352:428-33.
2. Trussell J, Rodriguez G, Ellertson C. Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception 1999;59:147-208.
3. Ho PC, Kwan MSW. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Hum Reprod 1993;8:389-92.
4. Fisher W, Boroditsky R, Morris B. The 2002 Canadian Contraception Study: Part I. J Obstet Gynecol Can 2004;26:580-90.
5. The Alan Guttmacher Institute. Sharing responsibility: women, society and abortion worldwide. New York: AGI; 1999.
6. Henshaw SK. Unintended pregnancy in the United States. Fam Plann Perspect 1998;30:24-9.
7. Statistics Canada. Induced abortions in hospitals and clinics, by area of report and type of facility performing the abortion, Canada, provinces and territories. Available at: http://www5.statcan.gc.ca/cansim/a05?lang=eng&id= 1069005; 2006. Accessed June 27, 2012.
8. Bayer Inc. Bayer expands women's health portfolio to include a new emergency contraceptive option: NorLevo® is now available in pharmacies across Canada without a doctor's prescription. Toronto: Bayer Inc.; May 26, 2009. Available at: http://www.bayer.ca/files/Norlevo%20press%20release-English- FINAL.pdf. http://www.bayer.ca/?q=en/node/1458. Accessed December 22, 2010.
9. United States Food and Drug Administration. Prescription drug products; certain combined oral contraceptives for use as post-coital emergency contraception. Fed Regist 1997;62:8610-2.
10. Glasier A, Thong KJ, Dewar M, Mackie M, Baird D. Mifepristone (RU486) compared with high-dose estrogen and progestogen for emergency post-coital contraception. N Engl J Med 1992;327:1041-4.
11. Ashok PW, Stalder C, Wagaarachchi PT, Flett GM, Melvin L, Templeton A. A randomized study comparing a low dose of mifepristone and the Yuzpe regimen for emergency contraception. Br J Obstet Gynecol 2002;109:553-60.
12. Task Force on Postovulatory Methods of Fertility Regulation. Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Lancet 1999;353:697-702.
13. Ashok PW, Wagaarachchi PT, Flett GM, Templeton A. Mifepristone as a late post-coital contraceptive. Hum Reprod 2001;16(1):72-5.
14. Xiao BL, von Hertzen H, Ahao H, Piaggio G. A randomized double blind comparison of two single doses of mifepristone for emergency contraception. Hum Reprod 2002;17(12):3084-9.
15. Glasier AF, Cameron ST, Fine PM, Logan SJ, Casale W, Van Horn J, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: randomized non-inferiority trial and meta-analysis. Lancet 2010;375(9714):555-62.
16. Hitt E. FDA panel gives ulipristal acetate unanimous positive vote for emergency contraception indication. Medscape News [Internet site]. Available at: http://www.medscape.com/viewarticle/723822. Accessed June 27, 2012.
17. Lippes J, Malik T, Tatum HJ. The postcoital copper-T. Adv Plan Parent 1976;11: 24-9.
18. Zhou LY, Ziao BL. Emergency contraception with multiload Cu-375SL IUK: a multicenter clinical trial. Contraception 2001;64:107-12.
19. Wu S, Godfrey EM, Wojdyla D, Dong J, Cong J, Wang C, et al. Copper T380A intra-uterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG 2010;117(10):1205-10.
20. Fasoli M, Parazzini F, Cecchetti G, La Vecchia C. Post-coital contraception: an overview of published studies. Contraception 1989;39:459-68.
21. American College of Obstetricians and Gynecologists. Emergency contraception. ACOG Practice Bulletin No. 112, May 2010. Obstet Gynecol 2010;115:1100-9.
22. Croxatto HB, Devoto L, Durant M, Ezcurra E, Larrea F, Nagle C, et al. Mechanism of action of hormonal preparations used for emergency contraception: a review of the literature. Contraception 2001;63:111-21.
23. Durand M, del Carmen Cravioto M, Raymond EG, Durán-Sánchez O, De la Luz Cruz-Hinojosa M, Castell-Rodríguez A, et al. On the mechanisms of action of short-term levonorgestrel administration in emergency contraception. Contraception 2001;64:227-34.
24. Hapangama D, Glaxier AF, Baird DT. The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle. Contraception 2001;63:123-9.
25. Croxatto HB, Fuentealba B, Brache V, Salvatierra AM, Alvarez F, Massai R, et al. Effects of the Yuzpe regimen, given during the follicular phase, on ovarian function. Contraception 2002;65:121-8.
26. Marions L, Hultenby K, Lindell I, Sun X, Stabi B, Bemzell Danielsson K. Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstet Gynecol 2002;100:65-71.
27. Raymond EG, Lovely LP, Chen-Mok M, Seppälä M, Kurman RJ, Lessey BA. Effect of Yuzpe regimen of emergency contraception on markers of endometrial receptivity. Hum Reprod 2000;15(11):2351-5.
28. Landgren BM, Johanisson E, Aedo AR, Kummar A, Shi Ye. The effect of levonorges-trel administered in large doses at different stages of the cycle on ovarian function and endometrial morphology. Contraception 1989;39:275-89.
29. Noé G, Croxatto HB, Salvatierra AM, Reyes V, Villarroel C, Muñoz C, et al. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception 2010;81:414-20.
30. Gemzell-Danielsson K. Mechanism of action of emergency contraception. Contraception 2010;82:404-9.
31. Trussell J, Raymond EG. Statistical evidence about the mechanism of action of the Yuzpe regimen of emergency contraception. Obstet Gynecol 1999;93:872-6.
32. Kesseru E, Garmendia F, Westphal N, Parada J. The hormonal and peripheral effects of dl-norgestrel in postcoital contraception. Contraception 1974;10:411-24.
33. Trussell J, Rodriguez G, Ellertson C. New estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception 1998;57:363-9.
34. Trussell J, Ellertson C, Stewart F. The effectiveness of the Yuzpe regimen of postcoital contraception. Fam Plann Perspect 1993;9:75-82.
35. Trussell J, Ellertson C, Dorflinger L. Effectiveness of the Yuzpe regimen of emergency contraception by cycle day of intercourse: implications for mechanism of action. Contraception 2003;67:167-71.
36. Trussell J, Ellertson C, von Hertzen H, Bigrigg A, Webb A, Evans M, et al. Estimating the effectiveness of emergency contraceptive pills. Contraception 2003;67:259-65.
37. von Hertzen H, Piaggio G, Ding J, Chen J, Song S, Bartfai G, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 2002;360:1803-10.
38. Arowojolu AO, Okewole IA, Adekunle AO. Comparative evaluation of the effectiveness and safety of two regimens of levonorgestrel for emergency contraception in Nigerians. Contraception 2002;66:269-73.
39. Ellertson C, Webb A, Blanchard K, Bigrigg A, Haskell S, Shochet T, et al. Modifying the Yuzpe regimen of emergency contraception: a multicenter randomized controlled trial. Obstet Gynecol 2003;101:1160-7.
40. Cheng L, Gulmezoglu AM, Piaggie G, Ezcurra E, Van Look PF. Interventions for emergency contraception. Cochrane Database Syst Rev Apr 16 2008(2):CD001324.
41. Trussell J, Ellertson C. Efficacy of emergency contraception. Fertil Control Rev 1995;4:8-11.
42. Piaggio G, von Hertzen H, Grimes DA, Van Look PFA. Timing of emergency contraception with levonorgestrel and the Yuzpe regimen. Lancet 1999;353:721.
43. Ellertson C, Evans M, Ferden S, Leadbetter C, Spears A, Johnstone K, et al. Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours. Obstet Gynecol 2003;101:1168-71.
44. Rodrigues I, Grou F, Joly J. Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected intercourse. Am J Obstet Gynecol 2001;184: 531-7.
45. United Nations Development Programme/United Nations Population Fund/World Health Organizations/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Post-Ovulatory Methods for Fertility Regulation. Efficacy and side effects of immediate postcoital levonorgestrel used repeatedly for contraception. Contraception 2000;61:303-8.
46. Dunn S, Brown TE, Alldred J. Availability of emergency contraception after its deregulation from prescription-only status: a survey of Ontario pharmacies. CMAJ 2008;178(4):423-4.
47. Society of Obstetricians and Gynecologists of Canada: sexualityandu [website]. S.O.S. Stay on schedule. Available at: http://www.sexualityandu.ca. Accessed June 28, 2012.
48. Espinos JJ, Rodriguez-Espinosa J, Senosiain R, Aura M, Vanrell C, Gispert M, et al. The role of matching menstrual data with hormonal measurements in evaluating effectiveness of postcoital contraception. Contraception 1999;60:215-20.
49. Wilcox A, Dundon D, Weinberg C, Trussell J, Baird DD. Likelihood of conception with a single act of intercourse: providing benchmark rates for assessment of post-coital contraceptives. Contraception 2001;63:211-5.
50. Stirling A, Glasier A. Estimating the efficacy of emergency contraception how reliable are the data? Contraception 2002;66:19-22.
51. Shelton JD. Repeat emergency contraception: facing our fears. Contraception 2002;66:15-7.
52. F, Yu W, Cheng L. Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study. Hum Reprod 2009;24:1605-11.
53. De Santis M, Cavaliere AF, Straface G, Carducci B, Caruso A. Failure of the emergency contraceptive levonorgestrel and the risk of adverse effects inpregnancy andon fetal development: an observational cohort study. Fertil Steril 2005;84:296-9.
54. Bracken MB. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Obstet Gynecol 1990;76: 552-7.
55. Improving access to quality care in family planning: medical eligibility criteria for contraceptive use. 3rd ed.Geneva: WHO; 2004.
56. Glasier A. Emergency postcoital contraception. N Eng J Med 1997;337:1058-64.
57. Grimes DA, Raymond EG, Scott Jones B. Emergency contraception over-the-counter: the medical and legal imperatives. Obstet Gynecol 2001;98:151-5.
58. Vasilakis C, Jick SS, Jick H. The risk of venous thromboembolism in users of postcoital contraceptive pills. Contraception 1999;59:79-83.
59. Webb A. How safe is the Yuzpe method of emergency contraception? Fertil Control Rev 1995;4:16-8.
60. Sheffer-Mimouni G, Pauzner D, Maslovitch S, Lessing JB, Gamzu R. Ectopic pregnancies following emergency levonorgestrel contraception. Contraception 2003;67:267-9.
61. Hatcher RA, Trussell J, Nelson AL, Cates Jr W, Stewart F, Kowal D. Contraceptive technology. 19th ed.New York: Ardent Media Inc.; 2007.
62. Cleland K, Raymond E, Trussell J, Cheng L, Zhu H. Ectopic pregnancy and emergency contraceptive pills: a systematic review. Obstet Gynecol 2010;115(6):1263-6.
63. Grimes DA, Schulz KF. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database Syst Rev 2001(2):CD001327.
64. Sinei SK, Schulz KF, Lamptey PR, Grimes DA, Mati JK, Rosenthal SM, et al. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion. Br J Obstet Gynecol 1990;97:412-9.
65. The International Consortium for Emergency Contraception. Emergency contraceptive pills: medical and service delivery guidelines. 2nd ed.Washington DC: The International Consortium for Emergency Contraception; 2004.
66. Raymond EG, Creinin MD, Barnhart KT, Lovvorn AE, Wountree RW, Trussell J. Meclizine for prevention of nausea associated with use of emergency contraceptive pills: a randomized trial. Obstet Gynecol 2000;95:271-7.
67. SoonJA, LevineM, Osmond BL, Ensom MHH, Fielding DW. Effectsofmaking emergency contraception available without a physician's prescription: a population-based study. CMAJ 2005;172(7):878-83.
68. Ellertson C, Ambardekar S, Hedley A, Coyaji K, Trussell J, Blanchard K. Emergency contraception: randomized comparison of advance provision and information only. Obstet Gynecol 2001;98:570-5.
69. Glasier A, Baird D. The effects of self-administering emergency contraception. N Engl J Med 1998;339:1-4.
70. Raine T, Harper C, Leon K, Darney P. Emergency contraception: advance provision in a young, high-risk clinic population. Obstet Gynecol 2000;96:1-7.
71. Polis CB, Schaffer K, Blanchard K, Glasier A, Harper CC, Grimes DA. Advance provision of emergency contraception for pregnancy prevention (full review). Cochrane Database Syst Rev Apr 18 2007(2):CD005497.
72. Sander PM, Raymond EG, Weaver MA. Emergency contraceptive use as a marker of future risky sex, pregnancy, and sexually transmitted infection. Am J Obstet Gynecol 2009;201:146-7.
73. Woolf SH, Battista RN, Angerson GM, Logan AG, Eel W, Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003;169:207-8.